Prognostic Value of Serum α-Fetoprotein Level as an Important Characteristic of Tumor Biology for Patients Undergoing Liver Resection of Early-Stage Hepatocellular Carcinoma (BCLC Stage 0/A): A Large Multicenter Analysis.

MLA

Yao, Lan-Qing, et al. “Prognostic Value of Serum α-Fetoprotein Level as an Important Characteristic of Tumor Biology for Patients Undergoing Liver Resection of Early-Stage Hepatocellular Carcinoma (BCLC Stage 0/A): A Large Multicenter Analysis.” Annals of Surgical Oncology, vol. 31, no. 2, Feb. 2024, pp. 1219–31. EBSCOhost, https://doi.org/10.1245/s10434-023-14525-w.

APA

Yao, L.-Q., Fan, Z.-Q., Wang, M.-D., Diao, Y.-K., Chen, T.-H., Zeng, Y.-Y., Chen, Z., Wang, X.-M., Zhou, Y.-H., Li, J., Fan, X.-P., Liang, Y.-J., Li, C., Shen, F., Lv, G.-Y., & Yang, T. (2024). Prognostic Value of Serum α-Fetoprotein Level as an Important Characteristic of Tumor Biology for Patients Undergoing Liver Resection of Early-Stage Hepatocellular Carcinoma (BCLC Stage 0/A): A Large Multicenter Analysis. Annals of Surgical Oncology, 31(2), 1219–1231. https://doi.org/10.1245/s10434-023-14525-w

Chicago

Yao, Lan-Qing, Zhong-Qi Fan, Ming-Da Wang, Yong-Kang Diao, Ting-Hao Chen, Yong-Yi Zeng, Zhong Chen, et al. 2024. “Prognostic Value of Serum α-Fetoprotein Level as an Important Characteristic of Tumor Biology for Patients Undergoing Liver Resection of Early-Stage Hepatocellular Carcinoma (BCLC Stage 0/A): A Large Multicenter Analysis.” Annals of Surgical Oncology 31 (2): 1219–31. doi:10.1245/s10434-023-14525-w.